Summary
The bioavailability of digoxin in solution was studied in 4 newborn infants with heart failure. Serum digoxin concentrations were determined by radioimmunoassay using125I. Bioavailability was estimated by comparison of the areas under the 8-h serum concentration curves (8-h AUC) after intravenous and oral administration of the glycoside. After oral administration of digoxin (1/4 of the digitalizing dose, 0.05 mg/kg bw), peak serum values of 2.3 – 4.4 ng/ml were reached within 30–90 min. After intravenous administration of the same amount of the glycoside, there was a rapid decrease in serum concentration during the first 2 h, and after about 4 h the serum concentration curves paralled those obtained after oral dosing. Based on within subject comparison of intravenous and oral 8-h AUC's, the mean bioavailability of digoxin was estimated to be 72 per cent (range 52 – 79 per cent). It was concluded that digoxin in solution, given to infants with mild to moderate heart failure, is well absorbed and biologically available to the same extent as in adults.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Andersson, K.-E., Bertler, Å., Wettrell, G.: Postmortem distribution and tissue concentration of digoxin in infants and adults. Acta paediat. scand.64, 497–504 (1975)
Bertler, Å., Redfors, A.: An improved method of estimating digoxin in human plasma. Clin. Pharmacol. Ther.11, 665–673 (1970)
Dengler, H.J., Bodem, G., Wirth, K.: Pharmacokinetic and metabolic studies with lanatoside C, α- and β-acetyldigoxin and digoxin in man. Pharmacology and the Future of Man. Proc. 6th Int. Cong. Pharmacology. San Fransisco 1972, vol. 3, 112–126, Basel: Karger 1973
Doherty, J.E.: The clinical pharmacology of digitalis glycosides: A review. Am. J. med. Sci.255, 383–414 (1968)
Dungan, W.T., Doherty, J.E., Harvey, C., Char, F., Dalrymple, G.W.: Tritiated digoxin. XVIII: Studies in infants and children. Circulation46, 983–988 (1972)
Döhlemann, Ch., Bühlmeyer, K.: Ergebnisse vergleichender oraler und intravenöser Digitalis-Therapie bei Säuglingen. Mschr. Kinderheilk.120, 458–461 (1972)
Fleckenstein, L., Kroening, B., Weintraub, M.: Assessment of the biologic availability of digoxin in man. Clin. Pharmacol. Ther.16, 435–443 (1974)
Greenblatt, D.J., Duhme, D.W., Koch-Weser, J., Smith, T.W.: Evaluation of digoxin bioavailability in single-dose studies. New Engl. J. Med.289, 651–654 (1973)
Gutcho, S., Mc Carter, H., Rapun, R.: Radio-immunoassay of digoxin: An intercomparison of results with three methods. Clin. chem.19, 1058–1059 (1973)
Hernandez, A., Burton, R.M., Pagtakhan, R.D., Goldring, D.I.: Pharmacodynamics of3H-digoxin in infants. Pediatrics44, 418–427 (1969)
Horgan, E.D., Ridey, W.J.: Radioimmunoassay of plasma digoxin with use of iodinated tracer. Clin. chem.19, 187–190 (1973)
Huffman, D.H., Kauffman, R.E.: Serum levels of digoxin. J. Pediat.82, 544–545 (1973)
Huffman, D.H., Manion, C.V., Azarnoff, D.L.: Absorption of digoxin from different oral preparations in normal subjects during steady state. Clin. Pharmacol. Ther.16, 310–317 (1974)
Iisalo, E., Dahl, M.: Serum levels and renal excretion of digoxin during maintenance therapy in children. Acta paediat. scand.63, 699–704 (1974)
Jusko, W.J.: Pharmacokinetic principles in paediatric pharmacology. Pediatr. Clin. N. Amer.19, 81–100 (1972)
Krasula, R.W., Pellegrino, P.A., Hastreiter, A.R., Soyka, L.F.: Serum levels of digoxin in infants and children. J. Pediat.81, 566–569 (1972)
Larese, R.J., Mirkin, B.L.: Kinetics of digoxin absorption and relation of serum levels to cardiac arrythmias in children. Clin. Pharmacol. Ther.15, 387–396 (1974)
Marcus, F.I., Kapadia, G.J., Kapadia, G.G.: The metabolism of digoxin in normal subjects. J. Pharmacol. exp. Ther.145, 203–209 (1964)
Neill, Catherine, A.: The use of digitalis in infants and children. Progr. cardiovasc.Dis.7, 399–416 (1965)
Nyberg, L., Andersson, K.-E., Bertler, Å.: Bioavailability of digoxin from tablets. 3. Availability of digoxin in man from preparations with different dissolution rate. Acta pharm. suecia11, 471–492 (1974)
Oliver, C.G., Taxman, R., Frederickson, R.: Influence of congestive heart failure on digoxin blood levels. Symposium on digitalis, Oslo, Norway. Ed. by O. Storstein, S. Nitter-Hauge, L. Storstein, p. 336–347, Oslo, Norway: Gyldendal Norsk Forlag 1973
Redfors, A.: Plasma digoxin concentration — its relation to digoxin dosage and clinical effects in patients with atrial fibrillation. Brit. Heart J.4, 383–391 (1972)
Rutkowski, Monika M., Cohen, S.N., Doyle, E.F.: Drug therapy of heart disease in pediatric patients. Part II. Amer. Heart J.86, 270–275 (1973)
Sanchez, N., Sheiner, L.B., Halkin, H., Melmon, K.L.: Pharmacokinetics of digoxin: Interpreting bioavailability. Brit. med. J.1973 IV, 132–134
Wagner, J.F., Christensen, M., Sakmar, E., Blair, D., Yates, J.D., Willis III, P.W., Sedman, A.J., Stoll, R.G.: Equivalence lack in digoxin plasma levels. J. Amer. med. Ass.224, 199–204 (1973)
Wettrell, G., Andersson, K.-E., Bertler, Å., Lundström, N.R.: Concentrations of digoxin in plasma and urine in neonates, infants, and children with heart disease. Acta paediat. scand.63, 705–710 (1974)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wettrell, G., Andersson, K.E. Absorption of digoxin in infants. Eur J Clin Pharmacol 9, 49–55 (1975). https://doi.org/10.1007/BF00613428
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00613428